Tipsheet
What matters at India’s listed companies
Specialty Chemicals · Mid cap

Sudarshan Chemical sets targets for its Heubach acquisition

The company expects the newly acquired Heubach pigment business to generate €35 million in EBITDA this year, with a path to €100 million within four years.


Mkt cap₹8,208 cr
ROE1.62%
Debt / eq.0.61
Div yld0.43%
€35 million Projected EBITDA for the Heubach business in the current financial year.

What's new

  • Sudarshan projects €700 million in sales and €35 million in EBITDA for Heubach this year.
  • Management targets €90–100 million in EBITDA within 3–4 years via cost savings and commercial gains.
  • Consolidated net debt dropped to ₹755 crore from ₹934 crore in Q4.

Why this matters

The market now has a concrete yardstick to measure the Heubach turnaround. Moving from insolvency to profitability is the immediate test, but the long-term viability of the deal hinges on hitting that €100 million EBITDA target.

What we're watching

  • Quarterly progress on the €35 million EBITDA target.
  • Further reduction in consolidated net debt levels.
  • Evidence of cost savings materializing in the coming quarters.

The full read

Sudarshan Chemical has provided its first explicit roadmap for the Heubach pigment business. Management expects the unit to deliver €700 million in sales and €35 million in EBITDA during the current financial year. This marks a recovery from the business's previous state under insolvency. Looking further ahead, the company targets €90–100 million in EBITDA within 3–4 years, relying on cost savings and commercial gains to bridge the gap. Deleveraging is also underway. Consolidated net debt fell to ₹755 crore from ₹934 crore in the previous quarter, aided by easing destocking and better working capital management. The guidance provides a clear trajectory for the acquisition, shifting the focus from integration to execution. The next test is whether the company can hit the €35 million EBITDA mark this year.

Questions answered

What is the financial outlook for the Heubach business?
Sudarshan expects the business to generate €700 million in sales and €35 million in EBITDA for the current financial year.
What is the long-term EBITDA target for the acquisition?
The company aims to reach €90–100 million in EBITDA over the next three to four years through cost savings and commercial gains.
How has the company's debt profile changed?
Consolidated net debt decreased to ₹755 crore, down from ₹934 crore in the previous quarter, as working capital improved.
What is driving the improvement in the Heubach business?
The company cites a recovery from the business's previous performance under insolvency, alongside planned cost savings and value capture initiatives.
Mentioned: Sudarshan Chemical Industries · Heubach
Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.